US equities
|
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
SNDK
$797.24
▲+0.00%
AMD
$503.41
▲+0.00%
SKHY
$122.61
▲+0.00%
SPCX
$141.70
▲+0.00%
ASML
$1,383.11
▲+0.00%
TSM
$359.69
▲+0.00%
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
SNDK
$797.24
▲+0.00%
AMD
$503.41
▲+0.00%
SKHY
$122.61
▲+0.00%
SPCX
$141.70
▲+0.00%
ASML
$1,383.11
▲+0.00%
TSM
$359.69
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about BPL/003
Recent news which mentions BPL/003
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers
NEWS
Tags
Beckley Psytech
BPL/003
Psychedelics
From
Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags
General
Psychedelics
Market News
From
Benzinga